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Differential relationships between apathy and
depression with white matter microstructural
changes and functional outcomes
Matthew J. Hollocks,1 Andrew J. Lawrence,1 Rebecca L. Brookes,1 Thomas R. Barrick,2
Robin G. Morris,3 Masud Husain4 and Hugh S. Markus1
Small vessel disease is a stroke subtype characterized by pathology of the small perforating arteries, which supply the sub-cortical
structures of the brain. Small vessel disease is associated with high rates of apathy and depression, thought to be caused by a
disruption of white matter cortical-subcortical pathways important for emotion regulation. It provides an important biological
model to investigate mechanisms underlying these key neuropsychiatric disorders. This study investigated whether apathy and
depression can be distinguished in small vessel disease both in terms of their relative relationship with white matter microstructure,
and secondly whether they can independently predict functional outcomes. Participants with small vessel disease (n = 118; mean
age = 68.9 years; 65% male) deﬁned as a clinical and magnetic resonance imaging conﬁrmed lacunar stroke with radiological
leukoaraiosis were recruited and completed cognitive testing, measures of apathy, depression, quality of life and diffusion tensor
imaging. Healthy controls (n = 398; mean age = 64.3 years; 52% male) were also studied in order to interpret the degree of apathy
and depression found within the small vessel disease group. Firstly, a multilevel structural equation modelling approach was used
to identify: (i) the relationships between median fractional anisotropy and apathy, depression and cognitive impairment; and (ii) if
apathy and depression make independent contributions to quality of life in patients with small vessel disease. Secondly, we applied
a whole-brain voxel-based analysis to investigate which regions of white matter were associated with apathy and depression,
controlling for age, gender and cognitive functioning. Structural equation modelling results indicated both apathy (r = 0.23,
P40.001) and depression (r = 0.41, P40.001) were independent predictors of quality of life. A reduced median fractional
anisotropy was signiﬁcantly associated with apathy (r = 0.38, P4 0.001), but not depression (r = 0.16, P = 0.09). On voxel-
based analysis, apathy was associated with widespread reduction in white matter integrity, with the strongest effects in limbic
association tracts such as the anterior cingulum, fornix and uncinate fasciculus. In contrast, when controlling for apathy, we found
no signiﬁcant relationship between our white matter parameters and symptoms of depression. In conclusion, white matter micro-
structural changes in small vessel disease are associated with apathy but not directly with depressive symptoms. These results
suggest that apathy, but not depression, in small vessel disease is related to damage to cortical-subcortical networks associated with
emotion regulation, reward and goal-directed behaviour.
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Introduction
People with cerebrovascular disease often present with
neuropsychiatric symptoms, with depression and apathy
being particularly prevalent, occurring in 30% of all
stroke (Hackett et al., 2014). Depressive symptoms
have been particularly associated with the cerebral
small vessel disease (SVD) subtype of stroke (Brookes
et al., 2014a). SVD is characterized by pathology of the
small perforating arteries, which supply the deep white
matter and grey matter structures of the brain, leading to
white matter lesions and lacunar infarcts, with 40% of
patients with lacunar stroke showing cognitive impair-
ment (Makin et al., 2013). The pathology is predomin-
antly subcortical, although recent data have suggested
microinfarcts may also occur in the cortical grey matter
(Smith et al., 2012).
It has been suggested that the increased prevalence of
depression in SVD (White et al., 2011) may be due in
part to the disruption of white matter pathways underlying
subcortical-cortical networks involved in mood regulation
(Brookes et al., 2014a), a hypothesis supported by an as-
sociation between MRI white matter hyperintensities and
late-life depression (O’Brien et al., 2006; Sneed et al., 2008;
Tang et al., 2010). Such symptoms are often undetected,
and have a signiﬁcant impact on quality of life (Brookes
et al., 2013). There is much less work on apathy in SVD,
although it has been suggested that it is particularly asso-
ciated with this stroke subtype (Moretti et al., 2015), and is
a common symptom in dementia patients with coexistent
white matter changes (Hahn et al., 2013).
A challenge in describing apathy in SVD is the consider-
able overlap with symptoms of depression, and the resultant
difﬁculty in differentiating the two clinically (Landes et al.,
2005). Apathy is deﬁned as a loss of, or diminished, motiv-
ation, in combination with reduction in either goal-directed
behaviour, cognitive activity or emotional expression (Marin
et al., 1991; Robert et al., 2009). However, reduced motiv-
ation is also an important factor in depression, and anhedo-
nia, or a loss of interest or pleasure, and is one of nine
primary symptoms of major depressive disorder in the
Diagnostic and Statistical Manual of Mental Disorders,
Fifth Edition (DSM-V) (Uher et al., 2013). Despite this sub-
stantial overlap, there is considerable evidence that apathy
and depression are distinguishable and dissociable from
each other (Marin et al., 1993; Starkstein et al., 2005;
Levy and Czernecki, 2006; van der Mast et al., 2008;
Kirsch-Darrow et al., 2011). It has been proposed that
apathy is caused by impairments in decision-making,
related to disruption of connections between the prefron-
tal cortex and the basal ganglia and other subcortical
structures, which prevent a person from integrating
‘emotional-affective signals’ with the selection of future
behaviour (Levy and Dubois, 2006).
Diffusion tensor imaging (DTI) is a non-invasive tech-
nique used to evaluate the structural integrity of white
matter in the brain, and has been shown to be sensitive
to white matter damage in SVD (van Norden et al., 2012;
Lawrence et al., 2013). DTI studies investigating white
matter changes associated with apathy and depression
in a variety of neurodegenerative conditions have
demonstrated considerable overlap between the two
(Apostolova et al., 2007; Cacciari et al., 2010;
Shackman et al., 2011; Hahn et al., 2013; Kim et al.,
2013; Spalletta et al., 2013; Stanton et al., 2013).
However, the interpretation of these studies is challen-
ging because apathy and depression are rarely studied
together in a single sample. To date there have been no
studies examining the white matter correlates of apathy
in people with SVD.
A recent meta-analysis of DTI studies identiﬁed a number
of white matter tracts associated with late-life depression
(Wen et al., 2014). Depression in SVD has previously been
associated with white matter damage (Brookes et al.,
2014a), as well as regional reductions in fractional aniso-
tropy in the genu and body of the corpus callosum, the
right anterior cingulum and the bilateral inferior fronto-
occipital fasciculus, uncinate fasciculus and corona radiata
(van Uden et al., 2015). However, it is currently unknown
whether any of these regions are related to apathy in SVD.
In this study we determined the prevalence of, and overlap
between, apathy and depression in patients with SVD,
using indices that have been developed in community-
based studies of ageing. We analysed the results using
structural equation modelling, which allows the concurrent
modelling of multiple linear associations testing both over-
all model ﬁt and individual path strength. The relationships
between white matter microstructure, apathy and depres-
sion were determined, while also quantifying their relative
contributions to quality of life, taking into account the
impact of any cognitive impairment. Finally, to provide
insights into the potential mechanisms of neuropsychiatric
comorbidities in SVD, we examined which regions of white
matter microstructure were speciﬁcally related to either
apathy or depression.
Materials and methods
Participants
Patients with symptomatic SVD (n = 121) were recruited to the
prospective longitudinal St. George’s Cognition and
Neuroimaging in Stroke (SCANS) study (Lawrence et al.,
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2013). This study includes data from baseline only. One par-
ticipant was excluded from the primary analysis due to
having missing questionnaire and cognitive data and a fur-
ther two participants were excluded from the voxel-based
analysis as they were unable to complete the MRI protocol.
SVD was deﬁned as a clinical lacunar stroke syndrome asso-
ciated with an anatomically appropriate lacunar infarct on
MRI, with additional conﬂuent leukoariosis rated as Fazekas
grade 2 or higher (Fazekas et al., 1987). Exclusion criteria
included any type of stroke other than SVD, including extra-
or intracranial large artery stenosis (550%), a cardio-
embolic source, non-lacunar subcortical infarcts which are
41.5mm in diameter, cortical infarcts or a history of any
other neurological or psychiatric disorder, with the exception
of depression. The study was reviewed and approved by the
Wandsworth research ethics committee. As a normal com-
parison we used data from 398 healthy controls recruited as
part of the Brief Memory and Executive Test multi-site val-
idation study (Brookes et al., 2012, 2015), but with over-
lapping questionnaire and background measures (Table 1).
Controls were recruited from local family doctors’ practices
or other volunteer groups. Individuals with cardiovascular
risk factors and other comorbidities were included, but indi-
viduals with a past history of stroke, transient ischaemic
attack, major central neurological or psychiatric disease
were excluded. All patient assessments were performed at
least 3 months post-stroke to reduce effects of acute ischae-
mia on cognition.
Questionnaire measures of apathy, depression and
quality of life
The Geriatric Depression Scale was used to measure depres-
sion. The Geriatric Depression Scale is a 30-item self-report
screening scale for depression that asks participants to
answer ‘yes’ or ‘no’ to questions concerning depression symp-
toms. The scale has good internal consistency ( = 0.86)
(Yesavage et al., 1983), and a sensitivity of 80% when com-
pared to clinical diagnoses of depression (Mitchell et al.,
2010). An ‘apathy scale’ was created using six of the
Geriatric Depression Scale items (Adams et al., 2004), and
consisted of the following items: ‘prefer to stay at home’,
‘avoid social gatherings’, ‘dropped activities and interests’,
‘ﬁnd life very exciting’, ‘hard to start new projects’ and ‘full
of energy’. The depression scale did not include the six apathy
items and had a range of 0–24, while the apathy scale had a
range of 0–6. To conﬁrm the use of these scales in our sample,
a conﬁrmatory factor analysis was conducted (see below).
The Stroke Speciﬁc Quality of Life Scale (SS-QoL) was
developed speciﬁcally to measure quality of life in stroke
trials, measuring multiple domains of quality of life as well
as providing a global score (Williams et al., 1999). Because
the SS-QoL was developed for a single post-acute stroke as-
sessment, the scale items were modiﬁed into the present tense
to reﬂect general current experiences (e.g. ‘I often have to stop
and rest during the day’). The SS-QoL has a speciﬁc domain
for mood problems, which for the purposes of this study was
not included in the total score, to minimize confounding effects
with the depression measure.
Neuropsychological measures
Assessment was performed by a neuropsychologist using a bat-
tery of widely-used tasks chosen to characterize the cognitive
impairment seen in SVD, and taking 2.5 h to administer.
Following a previously used methodology (Lawrence et al.,
2013), a series of cognitive index scores were created to sum-
marize performance across tasks for executive functioning,
processing speed and long-term memory, while a global cog-
nitive index score was produced which summarized perform-
ance across all tasks. For a list of the neuropsychological tasks
included in the global cognitive score and each index score
(Supplementary material). To construct index scores, the pri-
mary measures for each task were transformed into z-scores
using age-scaled normative data. These scores were aggregated
to form the indices by averaging the resulting measures show-
ing adequate internal consistency (executive functioning
 = 0.75, processing speed  = 0.65, long-term memory
a = 0.73, global index score  = 0.94) (Lawrence et al., 2013).
Table 1 Descriptive statistics of demographic and clinical variables for participants with SVD and controls
Measure (mean, SD) Control (n = 398) SVD (n = 118) t-test
Age (years) 61.9 (13.5) 69.9 (9.8) t = 2.6 (P4 0.01)
Gender (% male) 52 65 -
Geriatric Depression Scale – Apathy 1.5 (1.5) 2.7 (1.3) t = 8.8 (P4 0.01)
Geriatric Depression Scale – Depression 3.6 (3.4) 10.7 (3.1) t = 6.4 (P4 0.01)
Weight (kg) 74.0 (23.1) 76.5 (15.9) t = .86 (P = 0.37)
Systolic blood pressure (mmHg) 131.9 (17.2) 146.8 (21.5) t = 7.6 (P4 0.01)
Diastolic blood pressure (mmHg) 79.4 (10.1) 80.9 (10.8) t = 3.9 (P = 0.18)
Hypertension (%) 73 93 -
Hypercholesterolaemia (%) 73 88 -
Diabetes mellitus (%) 7 20 -
Current smoker (%) 10 20 -
Cognitive scores*
Global cognitive function - 0.58 (0.85) -
Processing speed - 0.73 (0.93) -
Executive functioning - 0.86 (1.1) -
Memory - 0.06 (0.99) -
Hypertension and hypercholesterolaemia are % being treated; *Cognitive scores are presented as mean z-scores.
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Diffusion tensor imaging
Images were acquired from a 1.5 T General Electric Signa
HDxt (General Electric), maximum gradient amplitude
33 mTm1, using a proprietary head coil. All sequences had
whole brain coverage and the total acquisition time was
45min. Axial single shot spin echo planar images were
acquired (repetition time/echo time = 15 600/93.4ms, ﬁeld of
view = 240  240 mm2, matrix = 96  96, 55 slices of
2.5mm with no slice gap). Eight volumes without diffusion
weighting (b = 0 smm2) were followed by 25 diffusion-
sensitized images with gradients applied in non-collinear direc-
tions (b = 1000 smm2). These acquisitions were repeated to
obtain four more unweighted volumes and the negative of
the 25 gradients.
Images were realigned to remove eddy current distortions
using FMRIB’s Linear Image Registration Tool (FLIRT)
(Jenkinson and Smith, 2001), part of the FMRIB Software
Library (FSL) (Smith et al., 2004; Jenkinson et al., 2012), ver-
sion 5.0. Slices with signal loss due to motion were identiﬁed
using an in-house intensity-based program and excluded from
further analysis. Most diffusion tensor images (111/118) were
identiﬁed as requiring some degree of correction by excluding
diffusion-weighted image slices with excessive patient move-
ment prior to computation of the DTI. In most cases slice
exclusion was minimal (median 8.5/2750 slices, interquartile
range = 14.75 slices). The maximum number of excluded slices
was 133 over 50 diffusion-weighted image volumes (i.e. there
are 55 slices per diffusion-weighted gradient direction image
meaning that 4.83% of slices for that individual were
excluded). All corrected and uncorrected diffusion tensor
images were visually inspected prior to further analysis.
Diffusion-weighted volumes with opposite gradients were geo-
metrically averaged to eliminate gradient cross-terms (Neeman
et al., 1991). The eight b = 0 smm2 images were co-registered
and the average taken to provide a T2-weighted echo planar
image, which we term the ‘b0’ image.
A mask which excluded non-brain tissue was created from
the b0 image using FSL’s Brain Extraction Tool (Smith, 2002).
Masks were inspected and manually corrected where
necessary.
Diffusion tensors were ﬁtted using the least squares method
(Basser et al., 1994) for each voxel of the brain mask by FSL’s
‘dtiﬁt’ program. The tensor was decomposed to create maps of
fractional anisotropy and mean diffusivity. When disease-
related white matter changes are present you would expect
to observe reduced fractional anisotropy, and increased mean
diffusivity values. Prior to voxel-wise analysis the fractional
anisotropy images underwent binary erosion with a
3  3  1 voxel kernel.
Voxel-based analysis
Analysis of fractional anisotropy and mean diffusivity maps
was conducted using a voxel-based analysis methodology
described by Schwarz and colleagues (2014). This combines
the use of an advanced registration technique implemented in
the Advanced Normalization Tools (ANTS) software (Klein
et al., 2009; Avants et al., 2011) with an iteratively generated
unbiased group-template to allow valid voxel-wise compari-
sons (Schwarz et al., 2014), similar to the voxel-based morph-
ometry technique (VBM) (Ashburner and Friston, 2000).
To create a standard fractional anisotropy template with min-
imal bias for use in the voxel-based analysis we adopted an
iterative procedure with three stages. Linear registrations were
implemented in FSL FLIRT using default settings (12 parameter
afﬁne transformation computed using the correlation ratio cost
function). First, a representative subject fractional anisotropy
image was linearly registered to the FMRIB58 fractional anisot-
ropy template provided with FSL. All images were linearly regis-
tered to this initial target and the mean average of these images
used to create an initial group template. The template was
updated with two further iterations of the above steps. The
ﬁnal mean average image was used to initialize a non-linear
template generated using ANTS via the buildtemplateparallel.sh
script (Avants et al., 2011). As a ﬁnal step, a linear transform-
ation was computed between the non-linear group template and
the FMRIB58 template. The above transformations bringing
fractional anisotropy and mean diffusivity maps in subject
space to the FMRIB58 template analysis space (via the group
template) were concatenated and the combined transform
applied in a single step to minimize interpolation errors.
Following previously used methodology, the voxel-based ana-
lysis of all subject images were smoothed using a Gaussian
kernel ( = 1mm) and analysis was restricted to voxels with
an average fractional anisotropy 50.2 representing regions of
mostly white matter (Schwarz et al., 2014).
In order to include whole white matter summary measures of
fractional anisotropy and mean diffusivity in the structural
equation model (see below) we extracted the median fractional
anisotropy and mean diffusivity for all non-zero white matter
voxels included within the voxel-based analysis mask using the
‘fslstats’ function in FSL.
Statistical analysis
We compared ﬁrstly the severity of apathy and depression be-
tween the SVD cases and controls and then thresholded the
scale using median splits to identify high and low scoring par-
ticipants, allowing us to establish the degree of overlap be-
tween apathy and depression in the group of patients with
SVD. To conﬁrm validity of the apathy subscale in our
sample, we conducted a conﬁrmatory factor analysis based
on the six factor model (Adams et al., 2004).
Structural equation model
Structural equation modelling is a statistical technique which
enables the testing of a theoretical model that includes a set
of directional (regression) and non-directional relationships
(covariances). This allows the quantiﬁcation of the independ-
ent contributions of predictor variables on outcome variables,
while accounting for dependencies between them. Here we
used multilevel structural equation modelling to investigate
the relationship between white matter microstructure and
apathy, depression, global cognitive impairment and the ﬁnal
outcome variable, quality of life; this was done within the SVD
sample. However, we also wanted to identify any independent
contributions of apathy, depression and global cognitive func-
tioning on quality of life. Overall, this allows us to estimate the
independent contributions of both apathy and depression on
quality of life while taking into account relationships with
white matter changes and any inter-relationships between the
other observed variables, age and IQ included, within the co-
variation matrix.
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For the structural equation modelling analysis, key variables
and covariates were included in an initial hypothesized model
(Fig. 1) and then pathways were dropped in a systematic fash-
ion to create alternate models for comparison, revealing the
most parsimonious model (Supplementary material). Models
were ﬁtted to raw data using full information maximum like-
lihood to account for data missing at random and alternative
models were compared using chi-square likelihood ratio test of
comparative model ﬁt, comparative ﬁt index (CFI), and root
mean square error of approximation (RMSEA), along with a
number of other parameters (Supplementary material).
Structural equation modelling and factor analysis was per-
formed in the statistical modelling software MPLUS version
5 (Muthe´n and Muthe´n, 2012).
Voxel-based analysis of diffusion images
To identify which regions of white matter may be speciﬁcally
associated with either apathy or depression, statistical analysis
was performed using the randomize program in FSL (Winkler
et al., 2014) with 10 000 permutations. A general linear model
was used to test positive and negative linear associations
between fractional anisotropy/mean diffusivity and (i) geriatric
depression scale-apathy score; and (ii) geriatric depression
scale-depression, controlling for global cognitive impairment
age and gender (dummy coded) as covariates of no interest
in a single model (a single general linear model was con-
structed for fractional anisotropy and mean diffusivity separ-
ately). Multiple comparisons were adjusted for using
threshold-free cluster enhancement (TFCE; H = 2, E = 0.5,
C = 6) and corrected P-values were thresholded at P40.01
and their spatial distribution compared with standard white
matter atlases (Harvard-Oxford Cortical and Subcortical
Atlas and Johns Hopkins University DTI-based white-matter
atlases) (Mori et al., 2005; Hua et al., 2008).
Results
Rates of depression and apathy in
patients with small vessel disease and
controls
Demographic characteristics of the patients with SVD and
control populations are shown in Table 1. The cases with
SVD had higher apathy (0–6) and depression (0–24) scores
than the controls; apathy mean [standard deviation (SD)]
2.7 (1.3) versus; 1.5 (1.5); P4 0.001; depression mean
(SD) 10.7 (3.1) versus 3.6 (3.4) P4 0.001. Using a
median cut-off of 3 for the apathy scale, and 10 for depres-
sion, 62/120 (52%) of participants with SVD had high
apathy and 67/120 (56%) had high depression. There
was considerable dissociation between apathy and depres-
sion, with 41/120 (34%) of the patients with SVD report-
ing co-occurring apathy and depression, but with an
additional 47/120 (39%) experiencing either apathy or de-
pression in isolation.
Confirmatory factor analysis of the
Geriatric Depression Scale
The conﬁrmatory factor analysis was conducted in
MPLUS. The literature has suggested a number of differ-
ent factor structures for the Geriatric Depression Scale,
with four factors being most common, with apathy/
social withdrawal consistently occurring as a single
factor (Kim et al., 2012). Our results suggested a six
factor structure, consistent with that found by Adams
and colleagues (2004), with adequate model ﬁt statistics
[2 (58) = 75, CFI = 0.96 RMSEA = 0.05]. Therefore, both
depression (0–24) and apathy variables (0–6) were
included in the structural equation model, as described
in the ‘Materials and methods’ section.
Structural equation model of the
relationships between white matter
microstructure and clinical measures
in SVD
Our initial model had adequate model ﬁt statistics
[2(2) = 3.8, P = 0.15; CFI = 0.99; RMSEA = 0.08, 90%
conﬁdence interval (CI) = 0.0–0.22] and found that while
reduction in white matter microstructure (median fractional
anisotropy) was a signiﬁcant predictor of greater apathy
scores (standardized coefﬁcient = 0.38, P4 0.001) and
more cognitive impairment (standardized coefﬁcient = 0.45,
P4 0.001), it was not signiﬁcantly related to symptoms of
depression (standardized coefﬁcient = 0.16, P = 0.07).
There was also a signiﬁcant direct effect of median frac-
tional anisotropy on quality of life (standardized coefﬁ-
cient = 0.23, P = 0.01). The model also revealed that
apathy (standardized coefﬁcient = 0.22, P = 0.01) and de-
pression (standardized coefﬁcient = 0.39, P4 0.001) both
Figure 1 Hypothesized model examining the relationship
between median fractional anisotropy/mean diffusivity,
apathy, depression, cognitive impairment and quality of
life. FA = fractional anisotropy; MD = median diffusivity. NART
errors and age are regressed onto all independent variables.
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independently predicted a poorer quality of life, while cog-
nitive impairment (standardized coefﬁcient = 0.12, P = 0.19)
did not. Apathy, depression and cognitive impairment were
all signiﬁcantly correlated with each other (all P4 0.05).
We then constrained non-signiﬁcant pathways to a value of
zero in order to test a number of alternative nested models
(Supplementary material). This resulted in a series of models
with adequate model ﬁt (Supplementary material) but with
Model 3 having ﬁt indices comparable to our hypothesized
model, to which it was identical, but with the non-signiﬁcant
path from cognitive impairment to quality of life being con-
strained to zero [2(3) = 5.4, P = 0.15; CFI = 0.98;
RMSEA = 0.08, 90% CI = 0.0–0.22; Fig. 2]. A 2 difference
test revealed no signiﬁcant difference between the hypothe-
sized model and Model 3 [2(1) = 1.6, P = 0.21], and there-
fore Model 3 was accepted as the most parsimonious.
We repeated the ﬁnal model substituting the median
fractional anisotropy value with median mean diffusivity,
and found consistent results [2(2) = 3.6, P = 0.16;
CFI = 0.99; RMSEA = 0.08, 90% CI = 0.0–0.22]. Again
we found that apathy (standardized coefﬁcient =
0.33, P40.001) and cognitive functioning (standardized
coefﬁcient = 0.37, P4 0.001), but not depression
(standardized coefﬁcient = 0.10, P = 0.52; Fig. 2), were
signiﬁcantly associated with median mean diffusivity
(Fig. 2). The correlations between all the key variables
included in the models can be found in Table 2.
Structural equation models of the
effect of cognitive domains on the
relationship between white matter
and apathy
To ensure the relationships between white matter
changes, apathy and depression were not mediated by
speciﬁc cognitive domains we conducted a post hoc ana-
lysis using executive functioning, memory and processing
speed performance instead of global cognitive function-
ing. The executive function [2 (2) = 2.9, P = 0.23;
CFI = 0.99; RMSEA = 0.06, 90% CI = 0.0–0.20], long-
term memory [2(2) = 2.7, P = 0.25; CFI = 0.99;
RMSEA = 0.06, 90% CI = 0.0–0.20] and processing
speed models [2(2) = 2.8, P = 0.25; CFI = 0.99;
RMSEA = 0.06, 90% CI = 0.0–0.20] all had adequate
model ﬁt statistics, and reliably showed that regardless
of the cognitive measure used, a reduced median frac-
tional anisotropy signiﬁcantly predicts more apathy,
poorer cognitive function and a worse quality of life,
but that depression was not signiﬁcantly related to
white matter changes (see Fig. 3 for full models). These
models are consistent with the previous analyses, con-
ﬁrming that the relationship between white matter
changes and apathy is maintained when accounting indi-
vidually for each of the following cognitive domains: ex-
ecutive functioning, memory and processing speed. These
models were repeated using the median mean diffusivity
value and showed consistent results (Fig. 3).
White matter correlates of apathy
and depression
Consistent with the structural equation model, when
controlling for depression, apathy was found to be signiﬁ-
cantly related to widespread changes in both fractional an-
isotropy and mean diffusivity (Fig. 4). Fractional
anisotropy and mean diffusivity associations with apathy
were primarily in anterior brain regions, but also areas
within the parietal and temporal lobes. This included sig-
niﬁcant results within the bilateral anterior cingulum,
corpus callosum, fornix, uncinate/inferior fronto-occipital
fasciculus and the anterior thalamic radiation, including
portions of the anterior limbs of the external capsule. In
contrast, when controlling for apathy, we found no signiﬁ-
cant relationship between our white matter parameters and
symptoms of depression. The analysis was also repeated
Figure 2 Final model depicting significant pathways between median fractional anisotropy/median diffusivity and apathy,
global cognition and quality of life in patients with SVD. FA = fractional anisotropy; MD = median diffusivity. NART errors and age are
regressed onto all independent variables. Dark lines represent significant paths (P4 0.05), while grey lines are non-significant paths. Note: the
non-significant path between Global Cognitive Impairment and Quality of Life was dropped to acquire best model fit. The values presented are
standardized b coefficients.
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using the whole Geriatric Depression Scale and again there
were no signiﬁcant ﬁndings. These ﬁndings strongly suggest
the involvement of limbic-cortical-thalamic-striatal circuits
in apathy in people with SVD. As the regions associated
with apathy in this analysis have previously been associated
with processing speed (Tuladhar et al., 2015), we repeated
the analysis speciﬁcally controlling for this cognitive
domain, ﬁnding consistent results (Supplementary material).
Discussion
In this study, we ﬁrst determined the presence of apathy
and depression in SVD compared to a large sample of
healthy controls, and investigated the overlap between
apathy and depression in SVD, before determining the re-
lationship between white matter microstructure and apathy,
depression and quality of life. Finally, we investigated re-
gional associations between white matter microstructure
and apathy to identify possible mechanisms that may
underlie these symptoms.
These results demonstrate that both apathy and depres-
sion are increased in patients with SVD, but that frequently
they do not occur together in the same patient. We found
that while 34% of patients with SVD displayed both symp-
toms concurrently, 39% had dissociated symptoms of
either depression or apathy. Of particular signiﬁcance is
our ﬁnding that 18% who are not depressed had high
levels of apathy as this may frequently be missed in the
clinical setting.
Despite evidence that apathy is a common neuropsychi-
atric symptom following stroke (Hackett et al., 2014), there
are little data on its impact on patients’ quality of life.
Previous studies in SVD have reported that both cognitive
functioning (Brookes et al., 2014b) and depression
(Brookes et al., 2013) following stroke are associated
with a poorer quality of life. Here we demonstrate that
both apathy and depression each have their own independ-
ent contributions to the quality of life in SVD. In our
model, cognitive impairment impacted indirectly on quality
of life through its association with apathy and depression.
This serves to highlight the importance of the assessment of
emotional neuropsychiatric symptoms such as apathy and
depression in patients with SVD. We also found a direct
path between white matter damage and quality of life. This
effect is most likely mediated by one or more factors not
included in the modelling because of model size constraints,
for example, physical disability or motor problems.
It has been suggested that the increased prevalence of
apathy and depression in SVD may be caused by white
matter damage to the cortico-subcortical pathways that
connect brain regions important for regulating emotion
(Taylor et al., 2013). DTI of these patients revealed that
white matter microstructural changes in SVD are associated
with increased apathy, but not depressive symptoms.
Spatial analysis identiﬁed a number of subcortical regions
Figure 4 Areas of reduced fractional anisotropy/median diffusivity associated with apathy in patients with SVD, controlling for
age gender and cognitive functioning. Images displayed using neurological convention. AC = anterior cingulum; ATR = Anterior Thalamic
Radiation; CC = corpus callosum; FA = fractional anisotropy; IFOF = inferior fronto-occipital fasciculus; MD = mean diffusivity; PC = posterior cingulum;
UF = uncinate fasciculus.
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commonly thought to be affected by SVD pathology as
underlying the association between white matter changes
and apathy (Prins et al., 2005). This included the anterior
cingulum, fornix, uncinate fasciculus, inferior frontal oc-
cipital fasciculus and the body and genu of the corpus
callosum.
The anterior cingulate cortex, goal-
directed behaviour and apathy
The cingulum is a large white matter tract underlying the
cingulate cortex (Shackman et al., 2011), which has been
linked to both affect regulation and cognitive control,
and has been associated with apathy in both structural
(Apostolova et al., 2007; Stanton et al., 2013) and func-
tional MRI studies (Marshall et al., 2007; Alexopoulos
et al., 2013). Consistent with our current ﬁndings, reduc-
tions in cingulum white matter integrity have also been
associated with apathy in patients with dementia and in
normal ageing (Cacciari et al., 2010; Kim et al., 2011;
Hahn et al., 2013; Spalletta et al., 2013). In particular,
lesions, including strokes, involving the anterior cingulate
cortex can lead to profound apathy often referred to as
abulia (Cohen et al., 1999; Grunsfeld and Login, 2006).
It has now been suggested that in conjunction with the
ventral striatal reward systems and frontal regions im-
portant for task initiation, the anterior cingulate cortex
has a role in the selection and maintenance task perform-
ance (Holroyd and Yeung, 2012). Given that, in addition
to the cingulum, we also found signiﬁcant associations
between apathy and areas of both the internal and exter-
nal capsules and diffuse regions of frontal white matter,
one hypothesis is that apathy in SVD is caused by dis-
ruption of the connections between frontal-striatal cir-
cuits, including the anterior cingulate cortex, which
select and initiate goal-directed behaviour based on pre-
vious reward information.
The fornix, episodic memory and
apathy
There was a signiﬁcant association between apathy and
white matter structural changes to the fornix and the an-
terior thalamic radiation. Reduction in fornix white matter
integrity has typically been associated with episodic
memory (Metzler-Baddeley et al., 2012). This suggests
that an ability to access autobiographical information
about times, places and their associated emotions or
reward value may be important in apathy. However, our
structural equation model revealed that performance on
memory tasks was not related to apathy scores. It is pos-
sible that the relationship between apathy and memory may
be isolated to only affective or reward related memories,
and future studies may be able to investigate this using
experimental paradigms rather than more generic neuro-
psychological tests.
The uncinate fasciculus, mnemonic
associations and apathy
Consistent with studies in Alzheimer’s disease (Hahn et al.,
2013), progressive supranuclear palsy (Agosta et al., 2014)
and normal ageing (Grool et al., 2014), we found a signiﬁ-
cant relationship between apathy and the uncinate fascic-
ulus. The uncinate fasciculus is considered to be important
for a range of cognitive functions such as episodic memory
(Metzler-Baddeley et al., 2012), linguistic ability (Papagno
et al., 2011) and social-emotional ability (Hornberger et al.,
2011). It has recently been demonstrated that apathy in
those with late-life depression is signiﬁcantly associated
with fractional anisotropy changes in the left uncinate fas-
ciculus and that reduced structural integrity in this region
may mediate treatment response (Yuen et al., 2014).
There was also a signiﬁcant association between apathy
and the inferior fronto-occipital fasciculus, both at its
Table 2 Pearson’s correlations between key variables included in the structural equation model
Median
FA
Median
MD
Depression Apathy Cognitive
function
Processing
speed
Executive
function
Memory Quality of
life
Age
Median FA 
Median MD 0.90** 
Depression
(GDS 0–24)
0.12 0.02 
Apathy (GDS 0–6) 0.38** 0.34** 0.51** 
Cognitive function 0.43** 0.37** 0.23* 0.32** 
Processing speed 0.23** 0.34** 0.10 0.20* 0.85** 
Executive function 0.23** 0.16# 0.02 0.01 0.28** 0.23* 
Memory 0.15 0.10 0.10 0.10 0.18* 0.18* 0.68** 
Quality of life 0.41** 0.38 0.65** 0.58** 0.35** 0.26* 0.11 0.01 
Age 0.06 0.01 0.12 0.14 0.09 0.10 0.18* 0.10 0.05 
NART 0.21* 0.15 0.14 0.06 0.66** 0.45** 0.10 0.13 0.03 0.14
GDS = Geriatric Depression Scale; FA = fractional anisotropy; MD = median diffusivity; NART = National Adult Reading Test; Cognitive function = global cognitive composite score;
# P4 0.10; * P4 0.05; ** P4 0.01.
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anterior termination in the frontal operculum, but also
more posteriorly (Fig. 3). The inferior fronto-occipital fas-
ciculus projects from the frontal operculum and proceeds
posteriorly passing though the insular to posterior temporal
lobe and ﬁnally the occipital lobe (Martino et al., 2010).
There is little evidence for a direct role for the inferior
fronto-occipital fasciculus in apathy. However, Stanton
and colleagues (2013) reported that a reduced insula
volume, as well as atrophy in the cingulate region, was
associated with high levels of apathy in patients with neu-
rodegenerative disorders.
Apathy or depression in small
vessel disease?
Given that our results are not consistent with the previous
ﬁnding in SVD that the white matter tracts implicated here
have a role in depressive symptoms, it is essential to discuss
why this may be. First, it is important to state that based
on this evidence alone, we are not suggesting that people
with SVD do not suffer from symptoms of depression.
Rather, these ﬁndings suggest that depression in SVD
may to some extent be secondary to motivational loss
and cognitive impairment, which are the more direct con-
sequence of white matter damage. Second, while our results
indicate that there is no direct association between white
matter integrity and depression, our data do suggest that
depression still has a signiﬁcant impact on functional out-
comes in patients with SVD.
Our results show a high level of correspondence with the
only other paper that has investigated regional associations
between white matter and depression in SVD (van Uden
et al., 2015). In that study, depressive symptoms were mea-
sured using the Centre for Epidemiologic Studies
Depression Scale (CES-D; Radloff, 1977). The CES-D
does contain some questions that tap into apathy, including
questions such as ‘I could not get going’ and ‘I talked less
than normal’, which may have driven the signiﬁcant asso-
ciations between depression and white matter microstruc-
ture in this study.
Conclusions, limitations and future
directions
Based on the results of this study we concluded that apathy
is a signiﬁcant symptom in people with SVD and is asso-
ciated with damage to white matter tracts which connect
regions in the frontal lobe with both subcortical structures
and the temporal lobe. Taking evidence from a wide range
of literature we have inferred that apathy may be caused by
damage to a number of networks responsible for the inte-
gration of reward, mnemonic associations and the selection
and initiation of goal-directed behaviour. Future research
should now focus on probing these regions with behav-
ioural and cognitive tasks designed to elicit reward-related
behaviour in combination with functional MRI. Adam
and colleagues (2013) have shown that a reward-based
decision-making task is sensitive to treatment of profound
apathy with a dopamine agonist in a patient with bilateral
basal–ganglia lesions as a result of ischaemic stroke. While
Kohno et al. (2010) demonstrated the potential beneﬁt of
Ropinirole, another dopamine receptor agonist, to reduce
apathy in a patient who had suffered an ischaemic lesion to
the prefrontal cortex.
This is the ﬁrst study to show speciﬁc relationships be-
tween white matter pathology and apathy in people with
SVD. We have also supported this by using structural equa-
tion modelling to demonstrate that both apathy and depres-
sion can be dissociated in SVD and have independent
associations with quality of life. However, future research
would beneﬁt from taking a more detailed approach when
assessing apathy. For instance, by using the Lille Apathy
Rating Scale (Sockeel et al., 2006), which divides apathy
into subdomains enabling the development of patient
speciﬁc proﬁles, also determining whether the current re-
sults can be replicated. Furthermore, although we carefully
selected our voxel-based analysis methodology (Avants
et al., 2011) to reduce common problems with voxel-
based methods (Ashburner and Friston, 2000; Bookstein,
2001), the localization of apathy within the white matter
should be interpreted with caution and replicated in an
independent sample of patients with SVD.
It is important to note that despite our ﬁndings that
apathy is signiﬁcantly related to white matter microstruc-
ture in SVD, even when controlling for cognitive function-
ing, some regions do overlap with those reported to be
associated with cognitive functioning. This is particularly
the case for processing speed, which has also been shown
to be related to diffuse white matter changes particularly in
frontal regions (Tuladhar et al., 2015).
This study has a number of clinical implications. Firstly,
our ﬁndings that apathy and depression are dissociable in
SVD, and that they both impact signiﬁcantly on patient
quality of life, suggests a more routine assessment of
apathy is warranted. Secondly, an ability to accurately dis-
tinguish between apathy and depression, whether they
occur together or in isolation from each other, may allow
the development of distinct treatment approaches for each.
For instance, while antidepressant treatments such as sero-
tonin re-uptake inhibitors (SSRIs) may be effective for
symptoms of depression (Salzman et al., 2002), they may
not be effective at treating apathy and its speciﬁc contribu-
tion to a person’s functional outcome. While there is lim-
ited literature on effective treatments for apathy, a number
of dopaminergic compounds have been suggested (Kohno
et al., 2010; Rosenberg et al., 2013; Thobois et al., 2013).
In addition, evidence suggests that the presence of symp-
toms of apathy reduces the effectiveness of treatments for
depression (Chaturvedi and Sarmukaddam, 1986; Ho¨ltta¨
et al., 2012). It is currently unclear whether this is only
due to a reduced engagement with the treatment regime
or if neurobiological differences between those who have
both symptoms of apathy and depression versus those with
3812 | BRAIN 2015: 138; 3803–3815 M. J. Hollocks et al.
depression alone may play a part. A clear delineation of
divergent properties of apathy and depression, both at the
behavioural level and the neurobiological level, may allow
the development of treatment plans for apathy itself or
treatments for post-stroke depression that take into account
the presence or absence of apathy.
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